Dong et al. [20] found that PRMT9 activity was elevated in the blasts and leukemia stem cells from patients with acute myeloid leukemia, and PRMT9 inhibition exerted antitumor effects by activating cyclic GMP‐AMP synthase. This evidence concerns the gene PRMT9 and acute myeloid leukemia.